Document is current

Article History

Received: 24 January 2018

Accepted: 13 February 2018

First Online: 15 March 2018

Authors’ information

: G.F. obtained his PhD in 2012 at the University of Barcelona and he is currently studying chronic lymphocytic leukemia as a postdoctoral trainee at the Karches Center for Oncology Research, The Feinstein Institute for Medical Research in New York. G.F. is author of more than 20 scientific publications.E.M. is now Professor of Medicine Emeritus at the Institute of Hematology and Oncology, Hospital Clínic, University of Barcelona. His main areas of interest are chronic lymphoproliferative disorders and lymphomas. E.M. is one of the founding members of the International Workshop on Chronic Lymphocytic Leukemia (IWCLL), the European Hematology Association (EHA) of which he has also been President, and the Society of Hematologic Oncology (SOHO). He is board member and past-president of the European Research Initiative on CLL (ERIC). E.M. is author of more than 300 scientific publications, board member and regular reviewer of high impact journals in hematology and oncology.

: Not applicable

: Not applicable

: The authors declare no competing financial interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.